Holly Magna - Niantic CT, US Paul Schaffer - Groton CT, US Michael Lawton - Westbrook CT, US Sue Yocum - Baltic CT, US Peter Mitchell - Mystic CT, US Nancy Hutchinson - Old Lyme CT, US Lynn Murry - Portola Valley CA, US
The invention provides a human nucleotide pyrophosphohydrolase-2 (NTPPH-2) and polynucleotides which identify and encode NTPPH-2. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating disorders associated with expression of NTPPH-2.
Holly Magna - Niantic CT Paul Schaffer - Groton CT Michael Lawton - Westbrook CT Sue Yocum - Baltic CT Peter Mitchell - Mystic CT Nancy Hutchinson - Old Lyme CT Lynn E. Murry - Portola Valley CA
Assignee:
Incyte Pharmaceuticals, Inc. - Palo Alto CA
International Classification:
C12Q 168 C12N 914 C12N 120 C07H 2104
US Classification:
435 6
Abstract:
The invention provides a human nucleotide pyrophosphohydrolase-2 (NTPPH-2) and polynucleotides which identify and encode NTPPH-2. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating disorders associated with expression of NTPPH-2.
Holly Magna - Niantic CT Paul Schaffer - Groton CT Michael Lawton - Westbrook CT Sue Yocum - Baltic CT Peter Mitchell - Mystic CT Nancy Hutchinson - Old Lyme CT Lynn E. Murry - Portola Valley CA
Assignee:
Incyte Genomics, Inc. - Palo Alto CA
International Classification:
A61K 3846 C12N 912 C12Q 142 C07H 2104
US Classification:
424 946
Abstract:
The invention provides a human nucleotide pyrophosphohydrolase-2 (NTPPH-2) and polynucleotides which identify and encode NTPPH-2. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating disorders associated with expression of NTPPH-2.
Peter Mitchell - Mystic CT Nancy Hutchinson - Old Lyme CT Michael Lawton - Westbrook CT Holly Magna - Niantic CT Sue Yocum - Baltic CT Lynn E. Murry - Portola Valley CA
International Classification:
C07H 2104 C12N 1563 C12N 1585
US Classification:
435 691
Abstract:
The invention provides a human nucleotide pyrophosphohydrolase (NTPPH-1) and polynucleotides which identify and encode NTPPH-1. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating disorders associated with expression of NTPPH-1.
Biphare
Chief Operations Officer
Zoetis Jul 1, 2013 - Nov 2015
Therapeutic Area Head
Pfizer Jul 2012 - Jul 2013
Lab Head Clinical Pharmacogenomics
Pfizer Jul 2007 - Mar 2011
Director Molecular Medicine, Inflammation and Dermatology Head
Pfizer Jul 2006 - Nov 2010
Director Mol Medicine
Skills:
Molecular Biology Drug Discovery Biomarkers Management Project Management Clinical Research Pharmacology Biomarker Discovery Lifesciences Clinical Development In Vitro Leadership In Vivo Drug Development Assay Development Translational Medicine Genomics Life Sciences Pharmaceutical Industry Biotechnology